Prenumeration
Beskrivning
Land | Finland |
---|---|
Lista | First North Finland |
Sektor | Hälsovård |
Industri | Medicinteknik |
Modulight Corporation, press release 21 February 2023 at 10:30 a.m. (Finnish time)
Modulight Corporation will publish its Financial Statement Bulletin 2022 on 23 February, 2023 at 1.00 p.m. EET.
Seppo Orsila, the CEO of Modulight, will present the results in a webcast on 23 February 2023 starting at 2.30 p.m. EET. The webcast will be held in English, and it can be accessed at https://modulight.videosync.fi/q4-22-results. CFO Anca Guina will also join the Q&A. Questions are requested in written format in the webcast portal. The material will be available on the company's website https://www.modulight.com/reports-presentations/ before the event begins.
For further information, please contact:
CEO: Seppo Orsila, m. +358 40 830 4671
IR: Ulla Haapanen m. +358 40 830 4676
Email: ir@modulight.com
Certified Adviser: Danske Bank A/S, Finland Branch, m. +358 40 414 5358
www.modulight.com
Twitter: @modulight, @orsila
Modulight in brief
Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight's products are used worldwide by many Fortune 500 companies, international pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.